Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation (Q46340364)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2008

edit

Language	Label	Description	Also known as
English	Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation	scientific article published in September 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

title

Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

main subject

nanoparticle

0 references

imatinib

1 reference

based on heuristic

inferred from title

author name string

Satoshi Kimura

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Kensuke Egashira

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Kaku Nakano

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Eiko Iwata

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Miho Miyagawa

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Hiroyuki Tsujimoto

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Kaori Hara

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Yoshiaki Kawashima

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Ryuji Tominaga

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

Kenji Sunagawa

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

language of work or name

English

0 references

publication date

1 September 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

published in

Circulation

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

volume

118

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

issue

14 Suppl

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

page(s)

S65-70

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

cites work

cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy

1 reference

stated in

COCI

retrieved

30 December 2023

reference URL

https://opencitations.net/index/api/v1/citations/10.1161/01.RES.0000185322.46009.F5

Identifiers

DOI

10.1161/CIRCULATIONAHA.107.740613

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

PubMed publication ID

18824771

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18824771

retrieved

21 December 2017

reference URL

http://europepmc.org/abstract/MED/18824771

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46340364&oldid=2106372499"